Brian Levy

Dr. Levy brings more than three decades of ophthalmic industry expertise in the development of ophthalmic therapeutics. He is currently the CEO of OcuNexus Therapeutics, a clinical stage ophthalmic biopharmaceutical company. Previously, he was the Chief Medical Officer (CMO) at Aerie Pharmaceuticals and a member of the executive management team that managed the company’s successful IPO. Prior to that he served as Sr VP of R&D and CMO for Bausch + Lomb. Dr. Levy has successfully led multiple drug and device approvals in the Ophthalmic sector in both the US and Internationally, including Europe and Asia. Dr. Levy earned a Doctor of Optometry degree from the University of California, Berkeley and a Master of Science degree in Comparative Anatomy and Physiology of the Eye at the University of Waterloo.